Proprietary AI analyst is now available
- Public Comps
- KDA Group
KDA Group Valuation Multiples
Discover KDA Group's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Innelec Multimedia, Fountain, Aspen Group, ACpay Co and more.
KDA Group Overview
About KDA Group
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.
Founded
2008
HQ

Employees
N/A
Website
Financials (FY)
EV
$11M
Valuation Multiples
Start free trialKDA Group Financials
KDA Group reported last fiscal year revenue of $117K and negative EBITDA of ($4M).
In the same fiscal year, KDA Group generated ($2M) in gross profit, ($4M) in EBITDA losses, and had net loss of ($6M).
KDA Group P&L
In the most recent fiscal year, KDA Group reported revenue of $117K and EBITDA of ($4M).
KDA Group is unprofitable as of last fiscal year, with gross margin of (1674%), EBITDA margin of (3484%), and net margin of (4866%).
Financial data powered by Morningstar, Inc.
KDA Group Stock Performance
KDA Group has current market cap of $11M, and enterprise value of $11M.
Market Cap Evolution
KDA Group's stock price is $0.05.
KDA Group share price decreased by 8.7% in the last 30 days.
KDA Group has an EPS (earnings per share) of $-0.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11M | $11M | -6.3% | -8.7% | - | - | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKDA Group Valuation Multiples
KDA Group trades at 92.1x EV/Revenue multiple, and (2.6x) EV/EBITDA.
KDA Group Financial Valuation Multiples
As of June 23, 2026, KDA Group has market cap of $11M and EV of $11M.
KDA Group has a P/E ratio of (1.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified KDA Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


KDA Group Margins & Growth Rates
In the most recent fiscal year, KDA Group reported gross margin of (1674%), EBITDA margin of (3484%), and net margin of (4866%).
KDA Group Margins
KDA Group Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
KDA Group Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
KDA Group Competitors
KDA Group competitors include Innelec Multimedia, Fountain, Aspen Group, ACpay Co, DM-KER, Longino & Cardenal, Bergholm, Ecomiam, High Quality Food and Harris Technology Group.
Most KDA Group public comparables operate across Wholesale Distribution and Business Services.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.2x | 0.2x | (28.1x) | 18.5x | |||
| 0.4x | - | 4.1x | - | |||
| 0.4x | - | (5.5x) | - | |||
| 2.2x | - | (3.2x) | - | |||
| 1.5x | - | 10.8x | - | |||
| 0.3x | 0.4x | 15.1x | 8.5x | |||
| 0.2x | - | 5.2x | - | |||
| 0.3x | 0.3x | (5.2x) | (8.9x) | |||
This data is available for Pro users. Sign up to see all KDA Group competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by KDA Group
KDA Group has acquired 3 companies to date.
Last acquisition by KDA Group was on July 4th 2016. KDA Group acquired Pharmapar for $15M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by KDA Group
| Description | Pharmapar is a Quebec-based family-owned distributor of generic drugs for privately insured individuals founded in 1998. The company sources pharmaceuticals from manufacturers like Apotex and Teva supplying over 1,500 community pharmacies across Quebec. Pharmapar focuses on high-demand generics in categories including cardiovascular, diabetes, and pain management tailored to private insurance reimbursement patterns. Operations from Laval warehouses ensure next-day delivery to pharmacies serving 2 million Quebec residents with supplemental coverage. Pharmapar partners with insurers like Desjardins and iA Financial for formulary alignment. | ProJ Pharma is a pharmacist staffing leader in Quebec, Canada. It supplies temporary and permanent pharmacy professionals to retail, hospital, and community health settings. As part of Groupe Projac, ProJ Pharma supports healthcare facilities across the province with flexible workforce solutions. | LIV Communication is a Toronto-based agency specializing in medical communications and sales training for pharmaceutical companies in Canada. It develops educational programs, slide decks, and workshops targeting unmet needs in oncology and cardiology. LIV supports clients like Pfizer and Novartis with compliant content for HCPs. |
| HQ Country | |||
| HQ City | Montreal | Quebec City | Montreal |
| Deal Date | 4 Jul 2016 | 4 Jul 2016 | 4 Jul 2016 |
| Valuation | $15M | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all KDA Group acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout KDA Group
| When was KDA Group founded? | KDA Group was founded in 2008. |
| Where is KDA Group headquartered? | KDA Group is headquartered in Canada. |
| Is KDA Group publicly listed? | Yes, KDA Group is a public company listed on Toronto Stock Exchange. |
| What is the stock symbol of KDA Group? | KDA Group trades under KDA ticker. |
| When did KDA Group go public? | KDA Group went public in 2009. |
| Who are competitors of KDA Group? | KDA Group main competitors include Innelec Multimedia, Fountain, Aspen Group, ACpay Co, DM-KER, Longino & Cardenal, Bergholm, Ecomiam, High Quality Food, Harris Technology Group. |
| What is the current market cap of KDA Group? | KDA Group's current market cap is $11M. |
| What is the current revenue of KDA Group? | KDA Group's last fiscal year revenue is $117K. |
| What is the current EV/Revenue multiple of KDA Group? | Current revenue multiple of KDA Group is 92.1x. |
| Is KDA Group profitable? | No, KDA Group is not profitable. |
| How many companies KDA Group has acquired to date? | As of June 2026, KDA Group has acquired 3 companies. |
| What was the largest acquisition by KDA Group? | $15M acquisition of Pharmapar on 4th July 2016 was the largest M&A KDA Group has done to date. |
| What companies KDA Group acquired? | KDA Group acquired Pharmapar, ProJ Pharma, and LIV Communication. |
| In how many companies KDA Group has invested to date? | KDA Group hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to KDA Group
Lists including KDA Group
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
